Expression of HAUSP in gliomas correlates with disease progression and survival of patients

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1737-1743

  Cheng, Chuandong ^a,b,c   Niu, Chaoshi ^a,b,c   Yang, Yang ^a   Wang, Yang ^a   Lu, Manman ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Stereotactic Neurosurgical Institute   (China)

^c University of Science and Technology of China   (China)

Author keywords

Deubiquitinating enzyme; Glioma; HAUSP USP7; Prognosis

Indexed keywords

HERPESVIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA; HAUSP GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN TUMOR; DISEASE COURSE; ENZYMOLOGY; GENETICS; MIDDLE AGED; PATHOLOGY;

BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; UBIQUITIN THIOLESTERASE;

EID: 84895640945     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2342     Document Type: Article

References (36)

1. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007. (Pubitemid 47103521)
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY and Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193, 2010.
3. Hershko A and Ciechanover A: The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998. (Pubitemid 28411135)
4. Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J: A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16: 1519-1530, 1997. (Pubitemid 27151947)
5. Sowa ME, Bennett EJ, Gygi SP and Harper JW: Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389-403, 2009.
6. Kessler BM, Fortunati E, Melis M, Pals CE, Clevers H and Maurice MM: Proteome changes induced by knockdown of the deubiquitylating enzyme HAUSP/USP7. J Proteome Res 6: 4163-4172, 2007. (Pubitemid 350158494)
7. Nicholson B and Suresh Kumar KG: The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys 60: 61-68, 2011.
8. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J and Pandolfi PP: The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455: 813-817, 2008.
9. van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM and Burgering BM: FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol 8: 1064-1073, 2006. (Pubitemid 44473601)
10. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C and Vogelstein B: Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428: 1 p following 486, 2004.
11. Li M, Brooks CL, Kon N and Gu W: A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13: 879-886, 2004. (Pubitemid 38438482)
12. Masuya D, Huang C, Liu D, Nakashima T, Yokomise H, Ueno M, Nakashima N and Sumitomo S: The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. J Pathol 208: 724-732, 2006.
13. Glickman MH and Ciechanover A: The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428, 2002. (Pubitemid 34654457)
14. Ciechanover A: The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17: 7151-7160, 1998.
15. Baek KH: Conjugation and deconjugation of ubiquitin regulating the destiny of proteins. Exp Mol Med 35: 1-7, 2003.
16. Grabbe C, Husnjak K and Dikic I: The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol 12: 295-307, 2011.
17. Komander D, Clague MJ and Urbé S: Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10: 550-563, 2009.
18. García-Santisteban I, Bañuelos S and Rodríguez JA: A global survey of CRM1-dependent nuclear export sequences in the human deubiquitinase family. Biochem J 441: 209-217, 2012.
19. Frappier L and Verrijzer CP: Gene expression control by protein deubiquitinases. Curr Opin Genet Dev 21: 207-213, 2011.
20. Song L and Rape M: Reverse the curse - the role of deubiquitination in cell cycle control. Curr Opin Cell Biol 20: 156-163, 2008.
21. Bergink S and Jentsch S: Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458: 461-467, 2009.
22. Ramakrishna S, Suresh B and Baek KH: The role of deubiquitinating enzymes in apoptosis. Cell Mol Life Sci 68: 15-26, 2011.
23. Muratani M, Gerlich D, Janicki SM, Gebhard M, Eils R and Spector DL: Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat Cell Biol 4: 106-110, 2002. (Pubitemid 34141475)
24. Faesen AC, Dirac AM, Shanmugham A, Ovaa H, Perrakis A, and Sixma TK: Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol Cell 44: 147-159, 2011.
25. Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik A and Reed JC: A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem 276: 24242-24252, 2001.
26. Maertens GN, El Messaoudi-Aubert S, Elderkin S, Hiom K, and Peters G: Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J 29: 2553-2565, 2010.
27. Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP and Bernards R: TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol 13: 102-108, 2010.
28. Du Z, Song J, Wang Y, et al: DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 3: ra80, 2010.
29. Faustrup H, Bekker-Jensen S, Bartek J, Lukas J and Mailand N: USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. J Cell Biol 184: 13-19, 2009.
30. Becker K, Marchenko ND, Palacios G and Moll UM: A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle 7: 1205-1213, 2008. (Pubitemid 351749274)
31. Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, Rich JN and Bao S: Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 13: 142-152, 2011.
32. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
33. Bertrand J, Begaud-Grimaud G, Bessette B, Verdier M, Battu S and Jauberteau MO: Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. Int J Oncol 34: 717-727, 2009.
34. Li G, Chen Z, Hu YD, Wei H, Li D, Ji H and Wang DL: Autocrine factors sustain glioblastoma stem cell self-renewal. Oncol Rep 21: 419-424, 2009.
35. Huang Z, Zhou W and Bao S: Role of deubiquitylase HAUSP in stem cell maintenance. Cell Cycle 10: 1182-1183, 2011.
36. Niu CS, Li DX, Liu YH, Fu XM, Tang SF and Li J: Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells. Oncol Rep 26: 593-601, 2011.